Avian sarcoma viruses (ASV) of subgroups A to D, produced by chick embryo fibroblasts (CEF), are inactivated to a high degree by rabbit antisera to the membrane antigens of adult chicken and chick embryo erythrocytes, notably by antisera to an antigen of embryo erythrocytes, which is lost by adult erythrocytes and to another antigen specific to the latter erythrocytes. Contrary to virus inactivation by anti-CEF serum reported earlier, virus inactivation by the antisera to these two age-specific antigens does not require complement and is not paralleled by virolysis but by aggregation of virions.
INTRODUCTION
Avian leukaemia and sarcoma viruses (ALSV) of the oncovirus family are, like all oncoviruses, enveloped viruses released by budding at the cell surface (Tooze, I973) . Consequently, in addition to virus-coded proteins (August et al. I974) , their envelope contains a variety of host cell components, some of which are antigenic (Aupoix & Vigier, I975; Lindenmann, I977) . In recent years, in the course of studies on cell permissiveness to virus replication, we have attempted to demonstrate and identify antigens of the host cell membrane on the envelope of ALSV with antisera to the cells used for producing the virus. Thus we have shown that avian sarcoma viruses (ASV) from the five main antigenic subgroups (A to E) of ALSV are all inactivated to a high degree by the serum of rabbits hyperimmun-* This article is dedicated to the memory of Mich~le Aupoix, who died in June I978, at the age of 33 years, in a car accident while returning from the Institut Curie in Orsay to her laboratory in Lyon. Her publications, in this and other journals, have established her name in the field of tumour virology. Those who have known her will also remember her remarkable human qualities.
ized against the chick embryo f~brob|asts (CEF) used for virus production, in the presence, but not the absence, of complement (C'; Aupoix & Vigier, I975) . The mechanism of this inactivation is virolysis (Aupoix & Vigier, I975; Aupoix et aL I976) , and the host cell surface antigen(s) (HCSA) detected on the virus envelope is not a protein coded for by the cryptic oncovirus (chf)of CEF, nor Forssman antigen, but a specific host cell surface antigen shared by CEF and Japanese quail embryo fibroblasts which seem to be free of chf It was also found (Vigier & Aupoix, I975) that virus activated in heterokaryons formed by fusion of non-permissive ASV-transformed hamster cells and CEF also carried CEF HCSA but no similar hamster antigen. Therefore, budding of the activated virus seems to be restricted to chicken-specific sites of the membrane, and HCSA may be required for virus maturation in CEF.
The presence of one or more host cell surface antigens on ASV produced by CEF and their possible role in permissiveness raised the question of whether this antigen is specific to CEF or also present on other cell types. This led us to start investigations with antisera to other types of chicken cells and, in the first place, to chicken erythrocytes. The reason for this choice was that the membrane antigens of chicken erythrocytes had been thoroughly studied by Blanchet (I976a, b) who had shown that they fall into two classes: (a) antigens common to adult and embryo erythrocytes (about I o in all) which are detected, in immunoelectrophoresis tests, by rabbit antisera to membranes of either adult chicken erythrocytes or I-day-old chick erythrocytes (antigenically similar to embryo erythrocytes), and (b) an age-specific antigen distinct for each type (i.e. adult-specific or embryo-specific) which is located on the outside of the membrane and detected by immunoelectrophoresis, immunofluorescence or haemagglutination, by homotypic antiserum absorbed with heterologous erythrocytes (i.e. anti-adult serum absorbed with embryo erythrocytes, for the adult-specific antigen, or vice versa). The embryo-specific antigen was also described by Sanders' group (Teplitz et al. I974; Sanders & Kline, 1975) who showed that it persists on peripheral erythrocytes until about 4 months after hatching, a finding confirmed by Blanchet (1976b) , and is also present on bone marrow erythrocytes and spleen, liver and kidney cells of adult chickens. On the other hand, some of the common erythrocyte antigens must also be present on CEF since unabsorbed anti-erythrocyte sera react strongly in immunofluorescence tests with unfixed CEF and, conversely, anti-CEF serum reacts strongly with unfixed adult or embryonic chicken erythrocytes (M. Aupoix & J. P. Blanchet, unpublished observations) .
We report here the first results of virus-inactivation experiments with unabsorbed and absorbed antisera to adult chicken and chick embryo erythrocyte membranes which show that ASV of A to D subgroups produced by CEF must all bear on their envelope, in addition to CEF HCSA, at least two other host-coded antigens related, or identical, respectively, to the two age-specific erythrocyte antigens. These two antigens do not appear to pre-exist, or pre-exist only in a low amount, on uninfected CEF, and their appearance or increase following infection does not depend on cell transformation but only on infection, since they are found on virus produced by untransformed CEF and on CEF infected by non-transforming Rous associated virus (RAV-I).
METHODS
Viruses, cells and media. The ASV of A, B, C and D subgroups used in our experiments were the same Rous sarcoma virus (RSV) strains which were used for the detection of CEF HCSA (Aupoix & Vigier, 1975) . RAV-1, the helper virus of Bryan strain RSV (Hanafusa et ak 1964 )~ was obtained from Dr H. Hanafusa (The Rockefeller University, New York). The cells (CEF) and media for virus production and titration were the same as for HCSA detection.
Sera. The immune sera to adult chicken or chick embryo erythrocyte membrane antigens * Virus in culture medium diluted with C'-free medium was incubated for I h at 37 °C with antiserum plus or minus C' (final dilution l : 6) and assayed as described in Methods.
t a-AE, Anti-adult erythrocytes, unabsorbed; a-AE/EE, anti-adult erythrocytes, absorbed on embryo erythrocytes; a-EE, anti-embryo erythrocytes; a-EE/AE, anti-embryo erythrocytes, absorbed on adult erythrocytes.
Relative to control without serum. Results of four experiments for each series.
were obtained by repeated inoculations of rabbits with purified erythrocyte membranes of White Leghorn adult chickens or 1-day-old chicks (Blancher, I976a). These sera were either unabsorbed and called respectively, anti-AE (for adult erythrocytes) or anti-EE (for embryo erythrocytes), or absorbed with the heterologous erythrocytes (Blanchet, 1976 b) and designated, respectively, anti-AE/EE or anti-EE/AE. The characteristics of these four sera have been described (Blanchet, 1976 a, b) . Absorption ofsera To investigate the relatedness to CEF HCSA of the antigens detected by the anti-erythrocyte sera and the influence of non-transforming infection on their appearance (cf. Results), the anti-erythrocyte sera were absorbed repeatedly on secondary CEF, either uninfected or infected with RAV-I. For these absorptions, I ml of serum, diluted with medium prepared with decomplemented calf serum (C'-free medium), was absorbed eight times on monolayers of about io 7 CEF in to cm Petri dishes, each time for I h at 37 °C. In control experiments, the specific anti-erythrocyte sera were also absorbed on homotypic erythrocytes (AE for anti-AE/EE serum and EE for anti-EE/AE serum) and anti-CEF serum (cf. Aupoix & Vigier, I975) on AE and/or EE. For these absorptions, I ml of diluted serum was incubated twice for I h at 37 °C with about io 9 erythrocytes. In all cases the unabsorbed control was diluted serum, heated at 37 °C for the same length of time as the total absorption time, and all absorbed or unabsorbed sera were decomplemented by heating for 30 min at 56 °C. This also inactivated RAV-1, in the case of sera absorbed with RAV-t-infected CEF.
Virus inactivation tests. These tests were carried out as described for virus inactivation by anti-CEF sera (Aupoix & Vigier, 1975) , i.e. virus-containing medium, diluted appropriately with C'-free medium, was incubated for I h at 37 °C with antiserum plus or minus C' (guineapig serum) and the mixture was then titrated by the focus assay on secondary CEF cultures, following 2o-fold dilution with C'-free medium. Virus survival was calculated relative to the titre of control mixtures in which either the antiserum or C' or both were replaced by decomplemented normal rabbit serum. This serum was adopted as control serum after it was seen that normal rabbit sera never inactivated RSV in the presence or the absence of C'. Electron microscopy studies. These studies were carried out as described earlier (Aupoix & Vigier, I975) .
RESULTS

Inactivation of D subgroup RSV by the anti-erythrocyte sera
As can be seen from Table i concentration I:6), reduced the virus titre by zo-to Iooo-fold and in most experiments, by at least Ioo-fold. No significant differences in reduction of the virus titre were noted between tests with anti-AE and anti-AE/EE serum on the one hand and tests plus or minus C' on the other. Therefore, in addition to CEF HCSA which is detected by anti-CEF serum only in the presence of C' (Aupoix & Vigier, I975) , the envelope of virus produced by CEF must bear an antigen related to or identical to the specific membrane antigen of adult erythrocytes and the mechanism of virus inactivation by antibodies to this antigen must be independent of C'. Fig. ~ further shows that the inactivation curves of the virus, as a function of the serum dilution, were also comparable for the two antisera and for tests with and without C'.
Incubation with anti-EE/AE serum (final concentration 1:48) also considerably reduced the virus titre (2o-to 6oo-fold), with or without C'. Therefore, in addition to HCSA and to the antigen related to the specific membrane antigen of adult erythrocytes, the virus envelope must bear another antigen related to or identical to the specific membrane antigen of embryo erythrocytes and the mechanism of inactivation by antibodies to this antigen must also be independent of C'. As with anti-AE sera, increasing dilutions of anti-EE/AE serum produce comparable virus-inactivation curves with and without C' (Fig. l) .
Incubation with unspecific anti-EE serum was also followed by reduction of the virus titre, but surprisingly this reduction was observed only in the presence of C' and was less marked 0o-to 15o-fold for a final serum concentration of I:24) than that observed in the presence of anti-EE/AE serum. Therefore, unabsorbed anti-EE serum recognizes on the virus envelope an antigen which must be distinct from the antigen related to the specific embryo antigen recognized by absorbed anti-EE/AE serum, but might be related to CEF HCSA, since the detection of both antigens requires C'. As seen from Fig. I and as could be expected, the inactivation curve of virus incubated with increasing dilutions of anti-EE serum plus C' is less steep than that of virus incubated with anti-EE/AE serum plus or 67 * The antisera, diluted 1 : IO with C'-free medium, were absorbed with homotypic erythrocytes (AE for a-AE/EE and EE for a -EE/AE), as described in Methods. The virus-inactivating capacity of the unabsorlzed (U) and the absorbed (A) sera was tested on SR-RSV-D, with or without C' (diluted I : 6). 
* Same experimental conditions and antiserum dilutions as in Table I . For the origin of viruses see Aupoix & Vigier (I975) . minus C' and, for a given concentration of anti-EE serum (i :24), inactivation also depends on C' dilution, as does inactivation by anti-CEF serum (Aupoix & Vigier, I975) .
A control experiment was performed to check that the antigens detected by the anti-AE sera and the anti-EE/AE serum were truly related or identical to the age-specific erythrocyte antigens. This experiment was based on the finding of Blancher (t976b) that these antigens are detected on whole unfixed erythrocytes by immunofluorescence or haemagglutination and must therefore be located on the outside of the membrane. Hence, the virus-inactivating capacity of the specific antisera should be removed by absorption with the homotypic erythrocytes (AE for anti-AE/EE serum and EE for anti-EE/AE serum). The experiments (Table 2) confirmed this prediction. On the other hand, as already stressed in Methods, no virus inactivation was observed, in the presence or absence of C', with normal rabbit sera.
Inactivation of virus of other subgroups (types)
Since no difference was observed between anti-AE and anti-AE/EE sera, the experiments were performed only with anti-AE, anti-EE and anti-EE/AE sera. Table 3 presents the results of inactivation of RSV of A, B and C subgroups (types). As can be seen, the results were the same as with D subgroup RSV. Therefore, the antigens related to the specific erythrocyte antigens detected by the anti-AE sera and the anti-EE/AE serum in the absence or presence of C' and the antigen(s) detected by the anti-EE serum in the presence of C' must be present in comparable amount on viruses of all subgroups. Tables I and 3 .
Independence of the presence of the antigens detected by the anti-erythrocyte sera on transformation of the virus-producing cells
Since the antigens detected by the anti-AE and anti-EE sera were found on RSV produced by transformed CEF, they could be present on virus produced by transformed cells but not on virus produced by untransformed ceils. We therefore investigated at the same time the presence of the antigens detected by the anti-erythrocyte sera on the ts mutant FUr 9 of SR-RSV-D produced by transformed CEF at 37 °C and by untransformed CEF at 4I °C (Biquard & Vigier, I972). As can be seen from Table 4 , the virus produced at 4t °C was inactivated by all sera to the same degree as the virus produced at 37 °C-Hence, the presence of the antigens detected by the anti-erythrocyte sera appears to be unrelated to cell transformation and to depend only on infection.
Pre-existence on CEF and relatedness to CEF HCSA of the antigens detected by the anti-erythrocyte sera
Findings with anti-AE sera and the anti-EE/AE serum clearly show that the antigens detected on ASV by these sera are distinct from CEF HCSA detected by anti-CEF sera. Therefore, they presumably do not pre-exist, or pre-exist only in low amount, on CEF and must appear or increase on the cell surface following infection. On the other hand, as already noted, the antigen(s) detected by the unabsorbed anti-EE serum could pre-exist on CEF since detection of this (these) antigen(s), as with CEF HCSA, requires C'.
Consequently, the specific anti-AE/EE and anti-EE/AE sera and the unspecific anti-EE serum were first absorbed repeatedly on uninfected secondary CEF (cf. Methods) and their capacity to inactivate SR-RSV-D following the absorptions was measured. The results are presented in Table 5 . As is seen, repeated absorptions on uninfected CEF of the specific anti-erythrocyte sera, pre-diluted 1:2o to 1:4o, failed to remove their virus-inactivating capacity, although dilution considerably reduced the activity of unabsorbed sera. Absorptions on CEF similarly failed to reduce the virus-inactivating capacity in the presence of C' of the unspecific anti-EE serum diluted io-fold prior to absorption and also of this serum pre-diluted 2o-fold, in one experiment out of two. Some reduction was observed in the second experiment; however, its significance is questionable. These results suggest that the antigens detected on the virus by the specific and unspecific anti-erythrocyte sera either do not pre-exist on CEF, or pre-exist only in low amounts, insufficient to absorb the corresponding antibodies in the sera.
In order to check that non-transforming infection elicits the appearance, or enhances the Erythrocyte antigens on avian oncoviruses 69 expression on CEF of the antigens detected on the virus by the anti-erythrocyte sera, these sera were also absorbed on CEF infected with RAV-I (cf. Methods). The results of the experiments also performed with SR-RSV-D are presented in Table 6 . As is seen, the activity of both the anti-AE/EE and the anti-EE/AE sera was reduced significantly by the absorptions, even though the dilutions before the absorptions were only I:~o f()r anti-AE/EE serum and I : 15 for anti-EE/AE serum. The anti-EE serum, diluted I : 5, was also absorbed on RAV-I-infected CEF, but its virus-inactivating capacity was not reduced significantly, although it was much less than that of the specific antisera. These data show that infection with RAV-I elicits the appearance or enhances the expression on CEF of the antigens detected on the virus by the specific anti-erythrocyte sera, but does not seem to enhance the expression of the antigen(s) detected by the non-specific anti-EE serum. Control experiments were also carried out with anti-CEF serum absorbed with either AE, or EE, or both. These absorptions failed to reduce the virus-inactivating capacity of the serum, even when it was diluted loo-fold before absorption (data not presented). Hence, if the antigen(s) detected by unabsorbed anti-EE serum is related to CEF HCSA, it is presumably not, or only partly, identical to the latter antigen(s). 
Electron microscopy studies
As can be seen from Fig. 2 , RSV particles incubated with anti-AE serum plus or minus C' did not display the swelling and loss of opacity characteristic of virolysis found earlier (Aupoix & Vigier, I975) after incubation with a n t i -C E F serum plus C', but only formed aggregates. Aggregation without virolysis was also seen following incubation of virus with anti-EE serum plus or minus C' and with a n t i -E E / A E serum minus C'. However, b o t h 
7I
aggregation and virolysis were observed with anti-EE/AE serum plus C' as with anti-CEF serum plus C'. These findings suggest that virus inactivation by the anti-erythrocyte sera in the absence of C' and also by the anti-AE and the unspecific anti-EE sera in the presence of C' is not due to virolysis but may, at least in part, follow aggregation of virions by antibody. However, aggregation is presumably not the entire explanation, since it also occurs, although to a lesser degree, after incubation with anti-EE serum without C' which does not inactivate the virus.
For comparison, the characteristics of virus inactivation by the anti-erythrocyte sera and anti-CEF serum have been summarized in Table 7 -
DISCUSSION
The data presented demonstrate that in addition to CEF HCSA, ASV of A to D subgroups produced by CEF bear on their envelope at least two other antigens related or identical, respectively to the two age-specific membrane antigens of chicken erythrocytes. These two antigens are detected by virus inactivation in the absence of C' by the absorbed antisera to erythrocyte membranes and the adult-specific antigen also appears to be detected in the absence of C' by unabsorbed anti-AE serum. Surprisingly, the unabsorbed anti-EE serum does not appear to detect the embryo-specific antigen but another non-specific antigen detectable only in the presence of C'. The reason for this unexpected finding remains unclear but could be the closeness of the specific and the non-specific antigens on the virus envelope which may cause interference of adsorption of antibodies to the former with adsorption of antibodies to the latter.
The absorption experiments with uninfected CEF and RAV-I-infected CEF further suggest that the two antigens related to the age-specific erythrocyte membrane antigens do not pre-exist, or pre-exist only in a low amount, on the membrane of uninfected CEF and therefore either appear or increase markedly on this membrane after infection. In agreement with this view, preliminary studies (J. Blanchet & V. Krsmanovic, unpublished results) have shown that the AE antigen is not detected on uninfected CEF by immunofluorescence or immunoprecipitation by the anti-AE/EE serum, whereas the EE antigen is detected only in a low amount by the anti-EE/AE serum. This low expression of the EE antigen may also result from the absence of some of its determinants, since it is complex (Dietert & Sanders, I977) . As for the non-specific EE antigen(s) detected by the anti-EE serum, the experimental data neither establish nor rule out its pre-existence on uninfected CEF. A further study of this problem is therefore required.
In any case the appearance or increase of the erythrocyte antigens does not seem to depend on transformation of the virus-producing CEF, since the antigens are present on FUI9 produced at 42 °C by untransformed CEF and on RAV-1-infected CEF. This further shows that infection by ALSV may elicit or enhance the expression of embryonic antigens in the absence of cell transformation. In this respect, it may be recalled that the embryonic erythrocyte antigen has been detected on other cell types of chick embryos and adult chicken (Teplitz et al. t974; Sanders & Kline, I975) . Moreover, one of us (Blanchet, 1976b) has observed the appearance after hatching of a population of erythrocytes bearing both agespecific antigens and persisting over 4 months which accounts for the persistence for that period of the embryonic specific antigen. Therefore, a common mechanism may release the joint expression of both antigens in some erythrocytes and may also become operational in infected CEF.
Although the Brown Leghorn CEF used in the experiments were chf +, gs + (Aupoix & Vigier, I976) , it is excluded that the endogenous virus played a role in the appearance of the erythrocyte antigens since, as CEF HCSA, these antigens have also been found by us on RSV produced by Japanese quail embryo fibroblasts which are chf-free. This last finding further supports the view, based on the earlier studies of Blanchet & Aupoix 0976) and of Teplitz et aL (t974) , that the two age-specific erythrocyte antigens must be cell-coded.
As far as the mechanism(s) of appearance or increase of the erythrocyte antigens is concerned, the following possibilities should be considered: unmasking of a cryptic antigen, alteration of a pre-existing antigen, or derepression of a repressed antigen. Moreover, the mechanisms may differ for the AE antigen which does not seem to pre-exist on CEF and the EE antigen which appears to be present already.
Concerning the nature of the erythrocyte antigens, preliminary studies indicate that they are proteins, or glycoproteins (Krsmanovic et al. 1979) . As regards their function, the high degree of virus inactivation observed with the absorbed antisera suggests that they are both present on all virions and therefore as CEF HCSA, both may be required for virus maturation. Thus their expression on the cell membrane near pre-existing specific host cell surface antigens might be necessary for constituting specific budding sites. It may also be relevant to recall that Friend leukaemia virus, isolated from the serum of various mouse strains, has been shown (Bubbers et al. I978) to incorporate selectively certain H-2 antigens, depending on the genotype of the host animal. However, these antigens were found only inside the virions and not on their envelope. The erythrocyte antigens and/or CEF HCSA might also be involved in the processing of the precursors of the virus non-glycosylated proteins and glycosylated proteins which appears to be a prerequisite for virus maturation (Eisenman & Vogt, I978) .
The efficient technical assistance of Mrs Y. Dooghe, D. Laugier and M. Williame is gratefully acknowledged. We also thank Miss M. F. Coquillon for the electron microscopy controls. Support for these investigations was received from the Institut National de la Sant6 et de la Recherche M6dicale (contract no. o2o).
